Abstract
If liver transplantation is not feasible, partial resection is considered the treatment of choice for hepatocellular carcinoma (HCC) in patients with cirrhosis. However, in some centers the first-line treatment for small, single, operable HCC is now radiofrequency ablation (RFA). In the current study, 218 patients with single HCC ≤ 2.0 cm (very early or T1 stage) underwent RFA. We assessed 2 primary end points that could be easily compared with those reported for resective surgery: (1) the rate of sustained, local, complete response and (2) the rate of treatment-related complications. The secondary end point was 5-year survival in the 100 patients whose tumors had been considered potentially operable. After a median follow-up of 31 months, sustained complete response was observed in 216 patients (97.2%). In the remaining 6, percutaneous ethanol injection, selective intraarterial chemoembolization, or resection were used as salvage therapy. Perioperative mortality, major complication, and 5-year survival rates were 0%, 1.8%, and 68.5%, respectively. Conclusion: Compared with resection, RFA is less invasive and associated with lower complication rate and lower costs. RFA is also just as effective for ensuring local control of stage T1 HCC, and it is associated with similar survival rates (as recently demonstrated by 2 randomized trials). These data indicate that RFA can be considered the treatment of choice for patients with single HCC ≤ 2.0 cm, even when surgical resection is possible. Other approaches can be used as salvage therapy for the few cases in which RFA is unsuccessful or unfeasible. (Hepatology 2007.)
Keywords
Hepatocellular carcinomaMedicineCirrhosisRadiofrequency ablationResectionAblationCarcinomaInternal medicineSurgeryGastroenterologyRadiologyGeneral surgery
MeSH Terms
AdultAgedAged80 and overCarcinomaHepatocellularCatheter AblationCohort StudiesFemaleHumansLiver CirrhosisLiver NeoplasmsMaleMiddle AgedRetrospective StudiesSurvival AnalysisTreatment Outcome
Affiliated Institutions
Related Publications
Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis
Abstract Fifteen patients with cirrhosis underwent orthotopic liver transplantation for small hepatocellular carcinoma (HCC) and 12 patients with cirrhosis underwent hepatic res...
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
During the 10-year period (1980 to 1989), 76 patients with hepatocellular carcinoma (HCC) were treated by subtotal hepatic resection (HX) and 105 patients by orthotopic liver tr...
Management of Hepatocellular Carcinoma: An Update Δσ
Since the publication of the American Association for the Study of Liver Diseases (AASLD) practice guidelines on the management of hepatocellular carcinoma (HCC) in 2005, new in...
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
The surgical indications for multiple hepatocellular carcinomas (HCCs) and for HCC with portal hypertension (PHT) remain controversial. We reviewed 434 patients who had undergon...
Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation
The growth rates of recurrent hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLTX) were estimated by calculating the tumor doubling time (TDT) in 20 pati...
Publication Info
- Year
- 2007
- Type
- article
- Volume
- 47
- Issue
- 1
- Pages
- 82-89
- Citations
- 1085
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1085
OpenAlex
31
Influential
874
CrossRef
Cite This
Tito Livraghi,
Maria Franca Meloni,
M. Stasi
et al.
(2007).
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?.
Hepatology
, 47
(1)
, 82-89.
https://doi.org/10.1002/hep.21933
Identifiers
- DOI
- 10.1002/hep.21933
- PMID
- 18008357